Activist & passive stakes
Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.
Showing the last 10 days.Sign up free for 90 days
All filings, new and amended.1–7 of 7
- PassiveAmendment 1Nov 16, 2026Radke Jeffrey L27% · 36,455,094 shSEC
- PassiveAmendment 1Nov 16, 2026ONeill Francis James5.8% · 7,418,545 shSEC
- PassiveAmendment 1Nov 16, 2026Lee-Smith Christopher15.9% · 20,530,284 shSEC
- PassiveAmendment 1Nov 16, 2026Zhen Li9.6% · 10,800,994 shSEC
- PassiveAmendment 1Below 5%Nov 13, 2026Capital Research Global Investors4% · 3,592,390 shSEC
- PassiveNewNov 13, 2026Zhen Li9.7% · 10,851,558 shSEC
- PassiveAmendment 1Below 5%Nov 13, 2026Capital International Investors4.9% · 3,738,933 shSEC
| Filing | Symbol | Holder | % Owned | Shares | Filed | SEC filing |
|---|---|---|---|---|---|---|
PassiveAmendment 1 | ARX | Radke Jeffrey L in Accelerant Holdings | 27% | 36,455,094 | Nov 16, 2026 | SEC |
PassiveAmendment 1 | ARX | ONeill Francis James in Accelerant Holdings | 5.8% | 7,418,545 | Nov 16, 2026 | SEC |
PassiveAmendment 1 | ARX | Lee-Smith Christopher in Accelerant Holdings | 15.9% | 20,530,284 | Nov 16, 2026 | SEC |
PassiveAmendment 1 | ADRX | Zhen Li in ADARx Pharmaceuticals, Inc. | 9.6% | 10,800,994 | Nov 16, 2026 | SEC |
PassiveAmendment 1Below 5% | ARXS | Capital Research Global Investors in Arxis, Inc. | 4% | 3,592,390 | Nov 13, 2026 | SEC |
PassiveNew | ADRX | Zhen Li in ADARx Pharmaceuticals, Inc. | 9.7% | 10,851,558 | Nov 13, 2026 | SEC |
PassiveAmendment 1Below 5% | ARXS | Capital International Investors in Arxis, Inc. | 4.9% | 3,738,933 | Nov 13, 2026 | SEC |